NIVF NewGenIvf Forward P/S Multiple
Streamlined supply chains for consumables in Asia minimize operational disruptions for NewGenIvf Group Limited. The forward price-to-sales ratio reflects current investor expectations, with the metric standing at 0.10. While a network of clinics and laboratories in Thailand and Cambodia ensures stability, legislative changes and regional demographic decline create certain risks for center occupancy rates.
NewGenIvf Corp (NIVF) - metric breakdowns and financial figures
- current price and projected stock value:
- market capitalization data:
- issuer book value statistics:
- debt and liquidity data:
Total Debt to Equity Ratio NewGenIvf Group Limited|NIVF - Long-Term Debt to Equity|Short-Term Debt to Capital NewGenIvf Group Limited|NIVF - Company Aggregate Indebtedness|Debt to Book Value NewGenIvf Corp|NIVF - Company Long-Term Loans and Borrowings|Company Short-Term Debts NewGenIvf|Quick Liquidity newgenivf.com
- business earnings and investment ratios data:
NIVF - Final Profit|Expected Profit NewGenIvf Group Limited|NIVF - Market Cap to Earnings|Projected Price to Earnings NewGenIvf Group Ltd|NIVF - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NewGenIvf Corp|NIVF - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share for the last 12 months NewGenIvf|NIVF - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months newgenivf.com|NIVF - Earnings per share growth in current year|Earnings growth forecast for next year NewGenIvf Group Limited
- sales and revenue indicators:
Fundamental valuation:NewGenIvf (NIVF)
The forward P/S ratio determines the market value of a company relative to expected revenue, measuring the premium for growth potential and the degree of investment optimism. By analyzing the history of the forward P/S, an investor assesses the valuation justification for NewGenIvf Group (NIVF), whose expansion into Southeast Asia's reproductive medicine sector and implementation of innovations should ensure a steady inflow of capital and business scaling.
Key competitors
Forward P/S Multiple HCA (HCA Healthcare)|Projected Price to Revenue Tenet Healthcare Corp|Fresenius Medical Care Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Solventum Health|Encompass Health (EHC) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue UHS|DVA (DaVita) - Forward P/S Multiple|RadNet Inc (RDNT) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple OPCH (Option Care Health Inc)|Price-to-Projected Revenue Ratio SGRY (Surgery Partners Group)|Forward P/S Multiple PINC (Premier, Inc.)|EYE (nationalvision.com) - Future Price to Revenue|PGNY: Forward Price-to-Revenue Multiple|Forward Price to Sales ARDT (Ardent Health)|SEM: Forward P/S Multiple|Projected Price to Revenue Astrana Corp ASTH|Price-to-Projected Revenue Ratio Pediatrix Corp|USPH: Forward Price to Sales|Price-to-Projected Revenue Ratio The Pennant Group (PNTG)|ORGO - Market Cap to Future Revenue Ratio|Nutex Health Corp - Forward Price-to-Revenue Multiple|Forward P/S Multiple Auna Corp AUNA|SBC - Price-to-Projected Revenue Ratio|Future Price to Revenue EOLS|CYH (Community Health Systems, Inc.) - Forward Price-to-Revenue Multiple|BeautyHealth - Forward Price to Sales|Price-to-Projected Revenue Ratio MediWound Ltd|Price-to-Projected Revenue Ratio BTMD|Forward P/S Multiple JYNT|Market Cap to Expected Sales Ratio docgo.com|Price-to-Projected Revenue Ratio P3 Health Partners PIII|GANX - Forward Price-to-Revenue Multiple|EUDA Health - Forward P/S Multiple|Market Cap to Expected Sales Ratio Basel Medical Group BMGL|CLGN (collplant.com) - Forward Price-to-Revenue Multiple|CUPR: Price to Expected Revenue Ratio|CCM (Concord Medical) - Forward P/S Multiple|Market Cap to Future Revenue Ratio American Shared Hospital Services Inc AMS|Forward P/S Multiple MRM|avalon-globocare.com - Market Cap to Projected Revenue|Price-to-Projected Revenue Ratio DIH Holding US, Inc. DHAI|XAGE: Market Cap to Projected Revenue|ATI Physical Therapy Corp - Forward P/S Multiple|Market Cap to Expected Sales Ratio CareMax Inc. CMAX|KDLY (Kindly MD Corp) - Forward Price-to-Revenue Multiple|MODV (ModivCare Corp) - Price-to-Projected Revenue Ratio|NVOS (Novo Integrated Sciences) - Forward P/S Multiple|SunLink Health Systems, Inc - Future Price to Revenue|Forward Price-to-Revenue Multiple BACK (IMAC Holdings)
